Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 13.11.2024
ARCA biopharma Мультипликаторы 2011-2024 | ABIO
Мультипликаторы по годам ARCA biopharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.3 | -3.0 | -1.4 | -2.6 | -1.3 | -0.8 | -1.0 | -1.4 | -2.1 | -1.5 | -2.5 | -2.1 | -1.9 |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.4 | -0.7 | -1.4 | -2.1 | -4.2 | -10.3 | -1.8 | -1.8 | -1.8 | -3.3 | -1.0 | -1.9 | -3.2 |
EV (Enterprise Value) |
-13.8 млн | -11.1 млн | -23.2 млн | -19.8 млн | -474 тыс. | 279 тыс. | 12.2 млн | 18.2 млн | -13.5 млн | 593 тыс. | 2.01 млн | 6.46 млн | 4.76 млн |
EBITDA per Share |
-0.51 | -0.73 | -1.39 | -1.6 | -4.33 | -10.5 | -31.7 | -32.3 | -32.7 | -59.5 | -101 | -242 | -509 |
EV/EBITDA |
1.8 | 2.1 | 0.2 | 0.1 | -0.5 | -1.0 | 1.3 | 0.1 | -0.1 | -1.4 | -0.6 | ||
PEG |
0.1 | 0.06 | 0.03 | -0.05 | -0.02 | -0.01 | -0.46 | -2.56 | -0.05 | -0.03 | -0.05 | -0.05 | -0.04 |
P/B |
0.6 | 0.7 | 0.5 | 0.5 | 0.9 | 1.0 | 1.8 | 1.0 | 0.6 | 1.0 | 1.1 | 3.1 | 1.7 |
P/CF |
-4.5 | -2.7 | -1.4 | -3.3 | -1.4 | -0.7 | -1.1 | -1.5 | -2.3 | -1.5 | -3.2 | -2.2 | -1.4 |
ROE % |
-14.42 | -23.82 | -37.85 | -20.93 | -72.04 | -131.48 | -179.79 | -74.18 | -30.06 | -65.73 | -44.54 | -148.61 | -93.58 |
ROA % |
-14.10 | -23.04 | -35.18 | -19.31 | -64.22 | -116.21 | -149.40 | -66.84 | -28.92 | -60.06 | -40.62 | -134.50 | -82.50 |
ROCE % |
-19.71 | -25.43 | -37.88 | -20.81 | -76.40 | -134.58 | -181.76 | -74.72 | -30.09 | -65.74 | -44.54 | -148.57 | -128.06 |
Current Ratio |
45.0 | 30.5 | 14.2 | 14.3 | 9.2 | 8.5 | 5.9 | 9.0 | 25.9 | 11.2 | 11.3 | 10.0 | 8.2 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально ARCA biopharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.46 | -0.18 | -0.14 | - | -0.1 | -0.1 | -0.09 | - | -0.16 | -0.22 | -0.23 | - | -0.33 | -0.34 | -0.33 | - | -0.33 | -0.73 | -0.83 | - | -0.76 | -1.14 | -1.86 | - | -2.06 | -2.74 | -3.61 | - | -0.39 | -0.59 | -0.48 | - | -0.51 | -0.43 | -0.4 | - | -0.31 | -0.69 | -0.91 | - | -0.76 | -0.11 | -0.13 | - | -0.16 | -0.65 | -0.35 | - | -0.41 | -0.09 | -0.69 | - | -0.17 | 0.03 | -0.25 |
EBITDA per Share |
- | - | -0.17 | - | - | - | -0.12 | - | -0.18 | -0.22 | -0.23 | - | -0.33 | -0.34 | -0.33 | - | -0.33 | -0.73 | -0.84 | - | -0.81 | -1.18 | -1.98 | - | -2.13 | -2.77 | -3.66 | - | -0.39 | -0.59 | -0.48 | - | -0.52 | -0.43 | -0.4 | - | -0.31 | -0.69 | -0.91 | - | -0.11 | -0.11 | -0.13 | - | -0.16 | -0.24 | -0.35 | - | -0.39 | -0.55 | -0.69 | - | -0.12 | 19.1 | -0.17 |
ROE % |
-25.24 | -20.63 | -16.18 | -13.78 | -13.66 | -15.37 | -18.60 | -22.10 | -30.40 | -33.27 | -34.17 | -33.56 | -33.46 | -29.41 | -32.53 | -37.33 | -42.42 | -53.33 | -58.43 | -63.52 | -72.10 | -83.31 | -91.89 | -100.46 | -116.63 | -133.36 | -288.63 | -443.89 | -477.14 | -508.09 | -402.23 | -222.28 | -252.34 | -208.31 | -164.28 | -90.19 | -155.92 | -191.58 | -227.25 | -197.18 | -241.72 | -220.53 | -199.33 | -133.61 | -282.21 | -386.28 | -490.36 | -445.82 | -539.40 | -484.37 | -429.35 | -280.74 | -93.58 | -93.58 | -93.58 |
ROA % |
-23.17 | -19.90 | -15.59 | -13.31 | -13.16 | -14.72 | -17.53 | -20.74 | -28.35 | -24.58 | -31.97 | -31.49 | -31.32 | -27.44 | -30.20 | -34.44 | -38.64 | -48.23 | -52.43 | -56.63 | -64.08 | -73.88 | -81.34 | -88.79 | -100.92 | -113.43 | -241.15 | -368.86 | -401.69 | -432.60 | -349.84 | -200.30 | -229.22 | -191.37 | -153.53 | -86.76 | -146.82 | -177.96 | -209.10 | -180.18 | -220.80 | -201.36 | -181.91 | -121.85 | -256.35 | -350.23 | -444.10 | -403.49 | -485.98 | -433.99 | -381.99 | -247.49 | -82.50 | -82.50 | -82.50 |
ROCE % |
-30.35 | -26.85 | -22.30 | -14.56 | -20.53 | -21.41 | -23.54 | -19.97 | -28.30 | -30.66 | -31.40 | -22.46 | -26.74 | -22.68 | -17.59 | -9.97 | -26.36 | -38.47 | -55.47 | -59.61 | -87.16 | -98.33 | -114.25 | -109.27 | -152.82 | -168.82 | -187.18 | -140.29 | -161.52 | -139.20 | -102.86 | -55.52 | -62.91 | -49.08 | -38.47 | -21.75 | -37.25 | -45.35 | -54.53 | -48.04 | -59.11 | -54.68 | -46.04 | -25.63 | -57.55 | -78.40 | -110.10 | -119.68 | -151.45 | -151.29 | -141.63 | -99.91 | -31.77 | -29.73 | -38.42 |
Current Ratio |
21.9 | 26.6 | 23.2 | 45.0 | 32.2 | 22.3 | 27.5 | 30.5 | 20.1 | - | 16.6 | 14.2 | 16.8 | 15.8 | 21.1 | 12.9 | 12.9 | 12.9 | 12.9 | 9.2 | - | - | - | 8.6 | 7.0 | 6.4 | 3.9 | 5.9 | 5.9 | 5.9 | 5.9 | 10.1 | 10.1 | 10.1 | 10.1 | 26.3 | 26.3 | 26.3 | 34.9 | 11.6 | 11.6 | 11.6 | 11.6 | 11.4 | 11.4 | 11.4 | 11.4 | 10.5 | 10.5 | 10.5 | 10.5 | 8.4 | 8.4 | 8.4 | 8.4 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD